Varian John 4
4 · SELLAS Life Sciences Group, Inc. · Filed Mar 15, 2018
Insider Transaction Report
Form 4
Varian John
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-03-13+11,000→ 11,000 totalExercise: $5.24Exp: 2028-03-12→ Common Stock (11,000 underlying)
Footnotes (1)
- [F1]The option shares will vest and became exercisable in equal monthly installments for thirty-six (36) months following the March 13, 2018 grant date, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.